Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis
- 11 December 2002
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 106 (6) , 351-354
- https://doi.org/10.1034/j.1600-0404.2002.01370.x
Abstract
Fundamentals and objective – Multiple sclerosis (MS) is the prototype of demyelinating disease, but recently, it has been shown that the existence of axonal lesions contribute to irreversible central...Keywords
This publication has 24 references indexed in Scilit:
- Axon loss in multiple sclerosisThe Lancet, 1998
- Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseasesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Axonal damage in acute multiple sclerosis lesionsBrain, 1997
- Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen speciesJournal of Neuroscience Research, 1995
- Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degenerationBiomedicine & Pharmacotherapy, 1994
- Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesisNeuropathology and Applied Neurobiology, 1994
- Evidence for increased lipid peroxidation in multiple sclerosisNeurochemical Research, 1992
- Multiple sclerosisJournal of the Neurological Sciences, 1992
- Update on the Epidemiology of Multiple SclerosisMayo Clinic Proceedings, 1989